faculty photo

Judy L. Meinkoth

Associate Professor of Pharmacology
Department: Pharmacology
Graduate Group Affiliations

Contact information
Department of Pharmacology
1251 BRB II/III
421 Curie Boulevard
Philadelphia, PA 19104-6160
Office: (215) 898-1909
Fax: (215) 573-2236
Education:
B.A. (Zoology)
Miami University, Oxford, Ohio, 1973.
Ph.D. (Biology)
University of California at San Diego, 1985.
Post-Graduate Training
Postdoctoral Fellow, Gene Expression Laboratory, The Salk Institute, La Jolla, CA, 1985-1987.
Postdoctoral Fellow, Cancer Center, University of California, San Diego, CA, 1988-1990.
Permanent link
 

Description of Research Expertise

Research Interests
Signal transduction, proliferation, differentiation, apoptosis.

Key words: signal transduction, proliferation, differentiation, apoptosis, Ras, Rap1, cAMP.

Description of Research
Dr. Meinkoth's laboratory is interested in normal and aberrant growth regulation in thyroid follicular cells, specialized epithelial cells that synthesize, secrete and store thyroid hormone. Thyrotropin or TSH, the physiological regulator of thyroid cell proliferation, differentiation and survival, elicits many of its effects through the ubiquitous second messenger, cAMP. In addition to activating PKA, cAMP activates small G proteins, specifically Ras and Rap1 in thyroid cells. The contributions of PKA, Ras and Rap1 to the regulation of cell proliferation, differentiation and survival are under investigation.

Ras mutations occur at high frequency in thyroid tumors where alterations in H-, K- and N-Ras have been identified. B-Raf mutations are also prevalent in thyroid tumors. Stable expression of oncogenic Ras in thyroid cells confers TSH-independent proliferation, induces dramatic morphological alterations and extinguishes differentiated gene expression. In contrast, acute expression of oncogenic Ras stimulates aberrant cell cycle progression and apoptosis. The molecular mechanism through which Ras deregulates cell cycle progression and stimulates apoptosis is under investigation. Identifying the secondary changes that transpire to allow the survival of cells expressing activated Ras is an area of active interest.

TSH activates Rap1 through a cAMP-dependent, PKA-independent signaling pathway. PKA phosphorylates Rap1, an event that may be required for downstream signaling. Using selective activators of EPAC, a Rap-specific guanine nucleotide exchange factor, and of PKA, the individual contributions of cAMP and PKA to the regulation of Rap1 activity and signaling are being investigated.

Selected Publications

Dong X, Korch C, Meinkoth JL: Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. Endocr Relat Cancer 18(3): 301-310, 2011.

Tsygankova OM, Ma C, Tang W, Korch C, Feldman MD, Lv Y, Brose MS, Meinkoth JL: Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Mol Cell Biol 30(13): 3262-3274, 2010.

Mei Y, Yong J, Liu H, Shi Y, Meinkoth J, Dreyfuss G, Yang X: tRNA binds to cytochrome c and inhibits caspase activation. Mol Cell 37(5): 668-678, 2010.

Vuchak LA, Tsygankova OM, Prendergast GV, Meinkoth JL: Protein kinase A and B-Raf mediate extracellular signal-regulated kinase activation by thyrotropin. Mol Pharmacol 76(5): 1123-1129, 2009.

Nellore A, Paziana K, Ma C, Tsygankova OM, Wang Y, Puttaswamy K, Iqbal AU, Franks SR, Lv Y, Troxel AB, Feldman MD, Meinkoth JL, Brose MS: Loss of Rap1GAP in papillary thyroid cancer. J Clin Endocrinol Metab 94(3): 1026-1032, 2009.

Smirnova EV, Collingwood TS, Bisbal C, Tsygankova OM, Bogush M, Meinkoth JL, Henderson EE, Annan RS, Tsygankov AY: TULA proteins bind to ABCE-1, a host factor of HIV-1 assembly, and inhibit HIV-1 biogenesis in a UBA-dependent fashion. Virology 372: 10-23, 2008.

Tsygankova OM, Prendergast GV, Puttaswamy K, Wang Yan, Feldman MD, Wang H, Brose MS, Meinkoth JL: Downregulation of Rap1GAP contributes to Ras transformation. Mol Cell Biol 27: 6647-6658, 2007.

Dworet JH and Meinkoth JL: Interference with 3',5'-cyclic adenosine monophosphate response element binding protein stimulates apoptosis through aberrant cell cycle progression and checkpoint activation. Molec Endocrinol 20: 1112-1120, 2006.

Fikaris AJ, Lewis AE, Abulaiti A, Tsygankova OM, Meinkoth JL: Ras triggers ataxia-telangiectasia-mutated and Rad-3-related activation and apoptosis through sustained mitogenic signaling. J Biol Chem 281: 34759-34767, 2006.

Abulaiti A, Fikaris AJ, Tsygankova OM, Meinkoth JL: Ras induces chromosome instability and abrogation of the DNA damage response. Cancer Res 66(21): 10505-10512, 2006.

back to top
Last updated: 06/27/2011
The Trustees of the University of Pennsylvania